These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35283015)
1. Odorant receptors in macrophages: potential targets for atherosclerosis. Wang C; Andreasson KI Trends Immunol; 2022 Apr; 43(4):262-264. PubMed ID: 35283015 [TBL] [Abstract][Full Text] [Related]
2. Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production. Orecchioni M; Kobiyama K; Winkels H; Ghosheh Y; McArdle S; Mikulski Z; Kiosses WB; Fan Z; Wen L; Jung Y; Roy P; Ali AJ; Miyamoto Y; Mangan M; Makings J; Wang Z; Denn A; Vallejo J; Owens M; Durant CP; Braumann S; Mader N; Li L; Matsunami H; Eckmann L; Latz E; Wang Z; Hazen SL; Ley K Science; 2022 Jan; 375(6577):214-221. PubMed ID: 35025664 [TBL] [Abstract][Full Text] [Related]
3. Reactive Oxygen Species-Responsive Nanoparticle Delivery of Small Interfering Ribonucleic Acid Targeting Olfactory Receptor 2 for Atherosclerosis Theranostics. Ni H; Zhou H; Liang X; Ge Y; Chen H; Liu J; Wang B; Chen H; Zhang Y; Luo S; Chen Y; Lu X; Yin C; Fan Q ACS Nano; 2024 Aug; 18(34):23599-23614. PubMed ID: 39141682 [TBL] [Abstract][Full Text] [Related]
4. Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway Mao J; Chen Y; Zong Q; Liu C; Xie J; Wang Y; Fisher D; Hien NTT; Pronyuk K; Musabaev E; Li Y; Zhao L; Dang Y Front Immunol; 2024; 15():1364161. PubMed ID: 38803504 [TBL] [Abstract][Full Text] [Related]
5. Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis. Qiao L; Ma J; Zhang Z; Sui W; Zhai C; Xu D; Wang Z; Lu H; Zhang M; Zhang C; Chen W; Zhang Y Circ Res; 2021 Dec; 129(12):1141-1157. PubMed ID: 34704457 [TBL] [Abstract][Full Text] [Related]
6. Olfactory receptors in macrophages and inflammation. Orecchioni M; Matsunami H; Ley K Front Immunol; 2022; 13():1029244. PubMed ID: 36311776 [TBL] [Abstract][Full Text] [Related]
7. NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis. Burger F; Baptista D; Roth A; da Silva RF; Montecucco F; Mach F; Brandt KJ; Miteva K Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008765 [TBL] [Abstract][Full Text] [Related]
8. Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis. Chen S; Wang Y; Pan Y; Liu Y; Zheng S; Ding K; Mu K; Yuan Y; Li Z; Song H; Jin Y; Fu J J Am Heart Assoc; 2020 Jun; 9(12):e015513. PubMed ID: 32476536 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice. Yin R; Zhu X; Wang J; Yang S; Ma A; Xiao Q; Song J; Pan X Ann Palliat Med; 2019 Nov; 8(5):676-689. PubMed ID: 31865729 [TBL] [Abstract][Full Text] [Related]
10. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice. Wang R; Wang Y; Mu N; Lou X; Li W; Chen Y; Fan D; Tan H Lab Invest; 2017 Aug; 97(8):922-934. PubMed ID: 28394319 [TBL] [Abstract][Full Text] [Related]
11. Ogg1-Dependent DNA Repair Regulates NLRP3 Inflammasome and Prevents Atherosclerosis. Tumurkhuu G; Shimada K; Dagvadorj J; Crother TR; Zhang W; Luthringer D; Gottlieb RA; Chen S; Arditi M Circ Res; 2016 Sep; 119(6):e76-90. PubMed ID: 27384322 [TBL] [Abstract][Full Text] [Related]
12. NFAT5 mediates hypertonic stress-induced atherosclerosis via activating NLRP3 inflammasome in endothelium. Ma P; Zha S; Shen X; Zhao Y; Li L; Yang L; Lei M; Liu W Cell Commun Signal; 2019 Aug; 17(1):102. PubMed ID: 31429763 [TBL] [Abstract][Full Text] [Related]
13. Activation of Nlrp3 inflammasomes enhances macrophage lipid-deposition and migration: implication of a novel role of inflammasome in atherogenesis. Li X; Zhang Y; Xia M; Gulbins E; Boini KM; Li PL PLoS One; 2014; 9(1):e87552. PubMed ID: 24475307 [TBL] [Abstract][Full Text] [Related]
14. Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction. Silvis MJM; Demkes EJ; Fiolet ATL; Dekker M; Bosch L; van Hout GPJ; Timmers L; de Kleijn DPV J Cardiovasc Transl Res; 2021 Feb; 14(1):23-34. PubMed ID: 32648087 [TBL] [Abstract][Full Text] [Related]
15. Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport. Luo J; Wang X; Jiang X; Liu C; Li Y; Han X; Zuo X; Li Y; Li N; Xu Y; Si S FASEB J; 2020 Jan; 34(1):1398-1411. PubMed ID: 31914630 [TBL] [Abstract][Full Text] [Related]
16. Exposure of cigarette smoke condensate activates NLRP3 inflammasome in THP-1 cells in a stage-specific manner: An underlying role of innate immunity in atherosclerosis. Mehta S; Dhawan V Cell Signal; 2020 Aug; 72():109645. PubMed ID: 32305666 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Inhibitory Capacities of 6-, 8- and 10-Gingerols/Shogaols on the Canonical NLRP3 Inflammasome-Mediated IL-1β Secretion. Ho SC; Chang YH Molecules; 2018 Feb; 23(2):. PubMed ID: 29466287 [TBL] [Abstract][Full Text] [Related]
18. NLRP3 inflammasome pathways in atherosclerosis. Baldrighi M; Mallat Z; Li X Atherosclerosis; 2017 Dec; 267():127-138. PubMed ID: 29126031 [TBL] [Abstract][Full Text] [Related]
19. Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition. Ma S; Chen J; Feng J; Zhang R; Fan M; Han D; Li X; Li C; Ren J; Wang Y; Cao F Oxid Med Cell Longev; 2018; 2018():9286458. PubMed ID: 30254716 [TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation. Wen J; Chang Y; Huo S; Li W; Huang H; Gao Y; Lin H; Zhang J; Zhang Y; Zuo Y; Cao X; Zhong F Aging (Albany NY); 2020 Nov; 13(1):910-932. PubMed ID: 33290264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]